Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fishman Chemical is a small U.S.-based supplier of pharmaceuticals and chemicals used in aquaculture, ornamental fish, koi, and aquarium health. The business appears to operate primarily as a commercial distributor and seller of fish medications rather than as a human biopharma developer with a clinical pipeline. Publicly available materials associate the company with products such as chloroquine phosphate, metronidazole, nitrofurazone, oxolinic acid, tetracycline, sulfadiazine, and sulfamethazine for fish-health applications. Its commercial presence is linked to the fishchemical.com email domain and to the National Fish Pharmaceuticals website, which provides fish disease reference content and ordering contact details. The company has also been referenced in an FDA animal-veterinary warning letter concerning marketing of an unapproved chloroquine phosphate product for fish.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fishman Chemical.